论文部分内容阅读
目的:探讨阿奇霉素治疗支气管哮喘的临床治疗效果。方法:选取我院自2010年8月至2012年8月期间收治的128例支气管哮喘患者的临床资料,将其随机分为两组;对照组64例患者行支气管扩张以及糖皮质激素等常规疗法;治疗组是在常规治疗的基础上加用阿奇霉素进行治疗,对比两组的治疗效果。结果:治疗组治疗总有效率为82.8%,对照组治疗后的总有效率为67.2%,治疗组的总有效率明显高于对照组,差异有统计学意义(P<0.05)。结论:在支气管哮喘治疗中,联合阿奇霉素进行治疗有治疗效果明显、不良反应少以及治疗时间短等优势,值得临床推广应用。
Objective: To investigate the clinical effect of azithromycin in the treatment of bronchial asthma. Methods: The clinical data of 128 patients with bronchial asthma admitted in our hospital from August 2010 to August 2012 were selected and randomly divided into two groups. In the control group, 64 patients received conventional therapy such as bronchiectasis and glucocorticoid The treatment group was treated with azithromycin on the basis of routine treatment, and the treatment effect was compared between the two groups. Results: The total effective rate of the treatment group was 82.8%, while that of the control group was 67.2%. The total effective rate of the treatment group was significantly higher than that of the control group (P <0.05). Conclusion: In the treatment of bronchial asthma, the combination of azithromycin has obvious curative effect, few adverse reactions and short treatment time, which is worthy of clinical application.